|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1994 |
|
Mechanism30S subunit inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1981 |
|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 1980 |
100 Clinical Results associated with Leshan Sanjiu Long March Pharmaceuticals Co. Ltd.
0 Patents (Medical) associated with Leshan Sanjiu Long March Pharmaceuticals Co. Ltd.
100 Deals associated with Leshan Sanjiu Long March Pharmaceuticals Co. Ltd.
100 Translational Medicine associated with Leshan Sanjiu Long March Pharmaceuticals Co. Ltd.